The Capital Grille
1338-46 Chestnut Street
Philadelphia, PA 19107
(215) 545-9588

Date: Thursday, September 7th, 12:00 pm (Doors open at 11:30 am)

Program Presenter:

Vin Singh, Founder and CEO


Speaker Biography

  • Founder & former CEO, Next Healthcare Inc.
  • Co-founder, MaxCyte Inc. – Nasdaq (MXCT) – $1.5B market cap
  • Global Director, Cell Therapy – ThermoFisher Scientific
  • B.S. Electrical Engineering, Rutgers University
  • M.S. Biomedical Engineering, Rensselaer Polytechnic Institute
  • MBA, The Johns Hopkins University



BullFrog AI, an emerging digital biopharma company, is committed to changing that paradigm.

Using our proprietary AI/ML analytics platform, we aim to improve drug development and clinical trials through identification of high-value data niches and patient subgroups. This will ultimately lead to improved clinical outcomes for patients, and reduction of trial-and-error treatment strategies in our disease areas of focus.

Our mission is to improve lives by identifying critical connections between therapies and highly responsive patients – in less time, with less cost, and more precision.